Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection
Conformable GORE® TAG® Thoracic Endoprosthesis First to Receive Indication for Aneurysm, Trauma and Dissection
Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms
Global Vascular Thought Leaders Document Shift toward Individualizing Patient Care in Surgical Bypass
Presentations and Discussions from the Surgical Bypass Summit Available at www.surgicalbypass.com
Gore Recognized as one of the World’s Best Multinational Workplaces by Great Place to Work®
Company earns No 4 spot
Gore Global Registry for Endovascular Aortic Treatment Reaches 2,500 Enrolled Patients
Milestone Achievement in Monitoring Patient Outcomes and Device Performance
First Patient Enrolled in GORE® TAG® Thoracic Branch Endoprosthesis Early Feasibility Study
First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms
Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure
Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone
Gore Joins Vascular and Endovascular Leaders in Recognizing the 2016 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
FDA Approves GORE® VIABAHN® Endoprosthesis for Revision of the Arteriovenous Access
Flexibility and Durability to Aid Hemodialysis Patients
Gore REDUCE Clinical Study Completes Enrollment
Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone